The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 523 KB) and Technical Notes (PDF, 687 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 1.3
| Primary Site | All Races | Whites | ||||
|---|---|---|---|---|---|---|
| Estimated Cancer Cases in 2008a |
Actual Cancer Deaths in 2008b |
U.S. Mortality Percent Change 1950-2008b |
5-Year Relative Survival Rates (Percent)c |
|||
| Total Percent Change |
APC | 1950-1954 | 2001-2007 | |||
| Oral cavity and pharynx | 35,310 | 8,019 | -52.5 | -1.3* | 46 | 65.1 |
| Esophagus | 16,470 | 13,714 | 27.7 | 0.8* | 4 | 19.6 |
| Stomach | 21,500 | 11,352 | -87.2 | -3.4* | 12 | 26.1 |
| Colon and rectum | 148,810 | 53,319 | -51.7 | -1.2* | 37 | 67.1 |
| Colon | 108,070 | 43,394 | -43.5 | -0.9* | 41 | 66.5 |
| Rectum | 40,740 | 9,925 | -70.3 | -2.4* | 40 | 68.7 |
| Liver and intrahepatic bile duct | 21,370 | 21,561 | 40.4 | 0.7* | 1 | 14.6 |
| Pancreas | 37,680 | 35,234 | 26.4 | 0.1* | 1 | 5.9 |
| Larynx | 12,250 | 3,760 | -34.0 | -0.7* | 52 | 64.9 |
| Lung and bronchus | 215,020 | 158,859 | 230.7 | 1.6* | 6 | 16.7 |
| Lung and bronchus (Males) | 114,690 | 88,740 | 155.6 | 0.9* | 5 | 14.5 |
| Lung and bronchus (Females) | 100,330 | 70,119 | 578.3 | 3.3* | 9 | 19.2 |
| Melanoma of the skin | 62,480 | 8,623 | 170.5 | 1.4* | 49 | 93.0 |
| Breast(females) | 182,460 | 40,589 | -33.0 | -0.5* | 60 | 91.4 |
| Cervix uteri | 11,070 | 4,008 | -81.7 | -3.3* | 59 | 70.3 |
| Corpus and uterus, NOS | 40,100 | 7,675 | -68.0 | -1.8* | 72 | 85.4 |
| Ovary | 21,650 | 14,771 | -7.9 | -0.2* | 30 | 43.3 |
| Prostate | 186,320 | 28,471 | -27.3 | -0.2 | 43 | 99.9 |
| Testis | 8,090 | 358 | -73.5 | -2.9* | 57 | 97.0 |
| Urinary bladder | 68,810 | 14,433 | -29.8 | -0.8* | 53 | 81.1 |
| Kidney and renal pelvis | 54,390 | 13,249 | 34.3 | 0.5* | 34 | 71.0 |
| Brain and nervous system | 21,810 | 13,724 | 50.2 | 0.5* | 21 | 33.7 |
| Thyroid | 37,340 | 1,649 | -39.6 | -1.2* | 80 | 97.6 |
| Hodgkin lymphoma | 8,220 | 1,171 | -80.1 | -3.3* | 30 | 87.5 |
| Non-Hodgkin lymphoma | 66,120 | 19,998 | 94.0 | 1.2* | 33 | 70.7 |
| Myeloma | 19,920 | 10,703 | 207.8 | 1.4* | 6 | 41.5 |
| Leukemia | 44,270 | 22,334 | 0.4 | -0.2* | 10 | 57.1 |
| Childhood (Ages 0-14) | 10,730 | 1,354 | -73.2 | -2.7* | 20 | 83.8 |
| All Sites | 1,437,180 | 565,460 | -10.9 | -0.1 | 35 | 68.6 |
Footnotes:
The APC is the Annual Percent Change over the time interval. Rates used in the calculation of the APC are age-adjusted to the 2000 U.S. standard population (18 age groups - Census P25-1130).
a Facts and Figures, 2008. American Cancer Society, Atlanta, Georgia, 2008.
b U.S. Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention. Due to coding changes throughout the years: Colon excludes other digestive tract; Rectum includes anal canal; Liver & intrahepatic bile duct includes gallbladder & biliary tract, NOS; Lung & bronchus includes trachea & pleura; Ovary includes fallopian tube; Urinary bladder includes other urinary organs; Kidney & Renal pelvis includes ureter; NHL and myeloma each include a small number of leukemias; NHL includes a small number of ill-defined sites.
c Survival estimates for 1950-54 are from NCI Survival Report 5 with the exception of All Sites, Oral cavity & pharynx, Colon & rectum, Non-Hodgkin lymphoma and Childhood cancers which come from historical Connecticut data. Survival estimates for 2001-2007 are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta). Rates are based on follow-up of patients into 2008.
* The APC is significantly different from zero (p<.05).
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.